Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

SVT-40776 progresses into phase II for urinary incontinence

June 17, 2004

Sosei's phase I trial of SOU-001 cleared to begin in U.K.

June 17, 2004

Therapeutic benefits of PT-141 plus Viagra in erectile dysfunction

June 16, 2004

PRECISE study to evaluate PhosLo plus Lipitor combination therapy

June 15, 2004

Urotensin-II receptor antagonist effective against renal ischemia in vivo

June 8, 2004

Second successful clinical study with VR-004 for erectile dysfunction

June 4, 2004

Sanctura receives FDA approval

June 3, 2004

Cizolirtine completes phase II trials in urinary incontinence

June 1, 2004

Ono scientists identify novel edg2 receptor antagonists

May 26, 2004

Lanthanum carbonate findings reported at NKF meeting

May 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...